875710-41-1

Upstream product

• 348-36-7 ethyl 5-fluoro-1H-indole-2-carboxylate 
• 456-42-8 m-fluorobenzyl chloride 

Downstream Products

• 1173656-74-0 N-(quinol-3-yl)-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide 
• 945912-32-3 N-(pyrido[1,2-a]benzimidazol-7-yl)-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide 
• 945910-77-0 N-(2,3-dihydro-1H-pyrrolo[1,2-a]benzimidazol-6-yl)-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide 
• 945910-73-6 N-(1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-7-yl)-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide 
• 945911-64-8 C₂₇H₂₃F₂N₅O 
• 945911-07-9 C₂₆H₂₁F₂N₅O 
• 897439-73-5 5-fluoro-1-[(3-fluorophenyl)methyl]-1H-indole-2-carboxylic acid 

Relevant academic research and scientific papers

TRICYCLIC N-HETEROARYL-CARBOXAMIDE DERIVATIVES CONTAINING A BENZIMIDAZOLE UNIT, METHOD FOR PREPARING SAME AND THEIR THERAPEUTIC USE

The invention concerns tricyclic N-heteroarylcarboxamide derivatives containing a benzimidazole unit of general formula (I): Wherein A, P, Y, R1, R2 and R3 are as defined herein. The invention also concerns a method of preparing the compounds and their therapeutic use.

N-(1H-INDOLYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

The invention relates to compounds of general formula (I): in which X1, X2, X3, X4, X5, Z1, Z2, Z3, Z4 and Z5, R, Y and n are as defined herein.

N-(HETEROARYL)-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS VANILLOID TRPV1 RECEPTOR LIGANDS

The invention concerns compounds of general formula (I), wherein n, X1, X2, X3, X4, Z1, Z2, Z3, Z4, Z5 and W are as defined herein. Said compounds are ligan